Board composition

Doug Baker currently serves as executive director of strategic partnerships at Labcorp. In this capacity, Doug works with leading pharma clients to assure delivery excellence and innovation across the Labcorp enterprise. Doug has nearly 30 years of experience in the clinical trial arena, as well as a background in hospital-based clinical microbiology.

Doug and his wife Christine reside in Brownsburg where they raised their four now-adult children. In his spare time, Doug enjoys writing, cooking, and gardening.

Doug Baker is an Indiana native and will always be a farm boy at heart. He is a graduate of Indiana University with a BS degree in microbiology and a second BS degree in psychology.

Todd Blake is a managing director in Deloitte’s Healthcare practice. He serves hospitals and physician practices to plan, select, implement, and optimize deployment of technology that improves professional productivity, patient safety, and clinical outcomes.

He has over 30 years of experience in management consulting, 20 of which come from the healthcare industry helping organizations plan and implement technology-enabled solutions. Throughout his career, he has focused on tools and techniques designed to accelerate the adoption of commercially developed software packages.

Todd is a graduate of Indiana University with a degree in computer science. He is based out of Deloitte’s office in Indianapolis where he lives with his wife and three daughters. He is an avid Indiana University sports fan, as well as a Colts and Pacers fan. He also enjoys the Indy 500 and various do-it-yourself projects around the house.

Responsibilities include the selection, deployment, and optimization of clinical, administrative, ERP, and supporting technologies. Consultative roles have included the identification, development, and leadership of cross-departmental, program-centric teams staffed with clients, vendors, and consultants to deliver complex, mission-critical improvements.

Bolinder, senior vice president, external engagement, and chief innovation officer, has served in the life sciences sector for 20 years, most recently as CEO and executive director of Acacia Pharma Group plc, a publicly listed group of companies with headquarters in both Indianapolis, Ind., and Cambridge, UK. Prior to Acacia, he served as head of marketing and commercial strategy for the hospital division of Mallinckrodt Pharmaceuticals, following their acquisition of Cadence Pharmaceuticals. Previously, he worked at Eli Lilly and Company in various commercial roles of increasing responsibility.

Diana Caldwell is co-founder, president and CEO of Amplified Sciences, an in-vitro diagnostics start-up company dedicated to the early detection of devastating disease with a lead assay in development for pancreatic cancer. She is an accomplished and recognized life science entrepreneur with over 25 years of experience in both large corporate and small entrepreneurial environments. Throughout her career, she has successfully driven organizational growth, developed and implemented strategic business plans, and directed successful teams. She is a serial life science entrepreneur dedicated to the acceleration of innovations improving patients’ lives.

Prior to taking helm as CEO of Amplified Sciences in June of 2019, Diana served as an entrepreneur in residence at the Purdue Foundry. Diana provided guidance to students, faculty, and alumni innovators to move their start-up ideas to commercially viable companies.

Early in her career, she worked for Eli Lilly for over 15 years in a variety of general management leadership roles in product management, marketing, finance, sales, and operations. Diana founded Pensar Ideas in 2009. Pensar Ideas is a business consultancy practice focused on business planning and strategy, fundraising, business operations and product development support, commercialization strategy, and sales and marketing support for life science companies.

In 2010, Diana co-founded Pearl Pathways where she led the company as president and CEO and oversaw all business operations, business development, legal, HR, and financial functions. Pearl Pathways is a life science product development consulting company focused on expediting regulatory pathways, building and enhancing quality management systems, delivering AHHRPP accredited IRB clinical research review services, and executing clinical trials through a niche CRO offering. Under her leadership she was able to scale the company to a multimillion-dollar company with fifteen employees and dozens of consultant partners. In 2018 she sold her interest in Pearl Pathways to pursue the start-up of another life science product company. Diana also lends her talents to several community organizations and not-for-profits including IHIF board of directors, IU Kelley School's Life Sciences advisory board, The ARC of Indiana Foundation board, and Senator Lugar’s Fund.

RJ was appointed as the Vice President and Associate General Counsel–Americas for Zimmer Biomet after the merger of Zimmer and Biomet in 2015. Prior to the merger, RJ was Division General Counsel for Biomet Orthopedics, Sports Medicine, Trauma and Biologics for several years. He joined Biomet in 2003 after spending several years as a trial attorney in Chicago, most recently with the law firm of Freeborn & Peters. During his tenure with Biomet and Zimmer Biomet, RJ has worked extensively with various senior management leaders involving multiple topics including health care law, mergers and acquisitions, licensing, and governmental/regulatory matters (e.g., Food and Drug Administration). RJ received his Bachelor of Arts degree from Indiana University in 1994 and his Juris Doctorate degree from the University of Dayton School of Law in 1997.

John Hauser is the vice president of Operations for Boston Scientific’s Spencer manufacturing facility where he leads the team of 1500+ individuals who support all aspects of operations at the Spencer site. In this role, he is the senior leader responsible for the site’s strategic direction, P&L performance and serves as is the Management with Executive Responsibility for Quality System operations. 

John joined Boston Scientific in 2007 as a manufacturing engineering manager in Arden Hills, Minnesota supporting the Cardiac Rhythm Management division before relocating to Dorado, Puerto Rico in 2012 as the site’s engineering director. In 2016, he went on to support an acquisition integration for the Neuromodulation division in California before joining Boston Scientific’s Process Development (PD) leadership team in 2017.

As a director and then vice president, John lead global teams supporting Endoscopy and Urology divisions in Massachusetts, Indiana, Costa Rica, India and Malaysia. He and his family relocated to Indiana when he joined the Spencer team in October 2020. 

As an advocate for DE&I, John sponsors the Spencer VETS employee resource group (ERG), an affinity group for Veterans and their allies. Throughout his career he has been a champion for women’s advancement as sponsor for Society of Women in Engineering (SWE), EXCELerate – a Boston Scientific program that promotes women’s professional growth, and Men Advocating for Real Change discussion groups. He has also been active in various Boston Scientific ERGs including the Young Professionals Network and HOLA – the internal affinity group for LatinX colleagues and their allies while also actively mentoring colleagues and emerging talent throughout the global Boston Scientific network. In 2023, John joined the Board of Directors for the Greater Bloomington Chamber of Commerce and actively supports the local business community and charitable organizations.

Prior to joining Boston Scientific, John spent 8 years in the U.S Navy’s submarine force serving as a Nuclear Engineering Officer on submarines in Virginia and Hawaii and spent two years as Officer-In-Charge of the Navy ROTC unit at Duke University. 

Outside of work, John is an avid golfer and enjoys travelling through the Caribbean with his wife Michelle. They enjoy finding incredible food in the cities they visit and enjoy frequent live music and comedy shows. They share their home with their rescue Golden Retriever (Hank) and are active volunteers with Golden Retriever rescue organizations in Indiana and Minnesota.

Jennifer Kowalski is the Vice President, Public Policy Institute, at Elevance Health, one of the nation’s leading health companies.

The Elevance Health Public Policy Institute works to advance meaningful change in the healthcare system through publication of policy-relevant data analysis, timely research, and insights from Elevance Health’s innovative programs. In her role as head of the Public Policy Institute, Jenn directs policy research and data analysis; convenes and connects with experts; supports external research; and oversees the production of papers, issue briefs, and other materials that contribute thought leadership to the health policy debate.  

Prior to joining Elevance Health, Jenn was Vice President at Avalere Health, a Washington, DC based health policy consulting firm, where she spent more than nine years. At Avalere, Jenn advised managed care and life sciences companies on policy and strategy related to health insurance reform and the Affordable Care Act, Medicare Advantage and Part D, and Medicaid. As co-director of the Health Reform Practice, she also led the strategic direction and day-to-day management of a practice of 30 professionals.

Previously, Jenn was a consultant at The Lewin Group, where she focused on quantitative analysis and program evaluation of mental health and substance use treatment initiatives. Jenn holds a Masters of Science in health policy and management from the Harvard University School of Public Health and a Bachelor of Arts in community health from Brown University. 

Matt Manley has 25 years of experience working in the In Vitro Diagnostic industry in customer engaging roles in strategy, marketing, sales and training. Over the past 15+ years with Roche, Matt has worked in solution portfolios covering Clinical Chemistry, Immunoassay, Molecular PCR - Point of Care, Coagulation Monitoring, Hospital Glucose POC and IT. During the global coronavirus pandemic, Matt helped lead Roche’s response, which delivered over 150 million tests at the Point of Care to the US market. Most recently, Matt has assumed a role within Roche as Vice President of Digital Healthcare Solutions business in the US. Roche’s ambition is to create value for patients, for healthcare systems, and ultimately, for society through advances in Digital Healthcare with a focus on early disease identification and detection.

Stephanie leads a team of experienced marketing and learning and development professionals to advance the practice of marketing at Eli Lilly & Company. Stephanie’s team leads talent development of marketers, sets standards and frameworks for launch excellence and brand leadership, consults with teams on critical strategic marketing decisions and upskills the worldwide marketing organization for the future, including a focus on data-driven decision making.

Since joining Lilly in 2011, Stephanie held multiple brand marketing roles with a heavy focus in consumer marketing, including leadership of a migraine launch. Her team’s work has resulted in building multiple new capabilities for the organization.

Prior to Lilly, she worked in consumer-packaged goods, creating product innovation and communication campaigns at Unilever and PepsiCo for brands such as Axe, Degree for Men, Dove and Quaker. Throughout her career, she has focused on uncovering and understanding deep, emotional insights from consumers, translating these insights into meaningful strategies and building resonant, powerhouse brands.

For her contributions she has earned multiple recognitions including: Brand Innovators 40 under 40; MM&M award for best use of Social Media, Gartner Digital IQ “Genius” Award, Top 25 DTC Marketer Award from DTC National. Stephanie holds an MBA from Northwestern’s Kellogg School of Management and a Bachelor of Science from Indiana University’s Kelley School of Business.

Bill is a pharmaceutical and biotech veteran who has spent his entire career with three pharmaceutical companies: Searle, Eli Lilly, and AbbVie. He spent the first 11 years of his career at Searle, which was later renamed Pharmacia, building traditional sales and marketing experience and gaining skills to eventually move into roles in U.S. and global marketing. Bill started as a sales representative in Madison, WI, which is a notoriously challenging staff-model managed care environment and that ignited his interest in market access.

After leaving Pharmacia in 2000, Bill moved to Eli Lilly and spent 18 years at the Indianapolis-based pharma company building expertise in U.S. and global market access strategy roles. He spent his first 10 years at Lilly as the launch Payer Marketing Director for both Forteo, a self-injectable osteoporosis treatment, and Cymbalta, a treatment for mood and pain disorders. After successfully leading the market access strategy creation for both launch brands, Bill moved to the global PRA organization to help build market access and key account management capabilities across Lilly’s global affiliates. He spent the last 6+ years as the global PRA lead for Lilly’s Alzheimer’s disease global diagnostic and treatment programs.

After a successful career at Lilly, Bill took early retirement and moved to AbbVie in early 2018. Since joining AbbVie’s global market access and pricing organization, he has held several roles leading early-phase market access strategy development for pipeline assets. He moved full-circle back to the U.S. Market Access organization at AbbVie to build a new team focused on integrating U.S. market access insights into early-phase asset development across AbbVie’s pipeline. 

Bill is an expert in U.S. and global pharmaceutical commercialization, with a deep expertise in pricing, reimbursement, and patient access. He has deep expertise in the U.S. health system including public (Medicare, Medicaid, IRA, etc.) and private (PBMs, MCOs, etc,) benefit designs, as well as key ex-U.S. health systems, such as those in Japan, France, Germany, Spain, UK, and other EU-based HTA systems.

Bill holds a B.S. in marketing from the IU Kelley School of Business.

Dan Peterson is vice president, industry & government affairs for Cook Group Incorporated based in Bloomington, Indiana. Since joining Cook in 1989, Dan has held a variety of leadership roles in the areas of operations, finance, accounting, and human resources. Dan’s current responsibilities involve industry, government, and external affairs. His primary areas of focus center on policies and programs in healthcare delivery as well as education, economic and workforce development.

Dan earned a BS in biology from Indiana University in 1984 and an MBA in finance also from Indiana University in 1989.

Dan serves on the board of directors for a variety of organizations throughout Indiana including BioCrossroads, Indiana Health Industry Forum, the Regional Opportunities Initiative, Inc., and the Bloomington Economic Development Corporation. Dan also serves as chairman of the South Central Regional Board of Indiana University Health, and is one of the founding board members for the Indiana Bioscience Research Institute. Dan serves as a commission member of the Indiana Commission for Higher Education and is the immediate past chairman.

Since 1963, Cook Group companies are combining medical devices, biologic materials, and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. Cook Group companies employ more than 12,000 people globally with operations in North America, Europe, and Asia-Pacific. Today, Cook manufactures more than 16,000 products that serve more than 40 medical specialties in 135 countries.

Lesley Snyder serves as Chief of Staff – System Regional Operations and System Nursing for Indiana University Health. In her role as Chief of Staff, she is a trusted adviser to the Executive Vice President Chief Nurse Executive and the Senior Vice President System Regional Operations, facilitates and executes operational and strategic initiatives, serves as a liaison between key system and regional departments and community leaders, and manages internal and external communications.

She began her career with IU Health in 2008 and has served in a variety of operational and leadership roles throughout her career including Chief of Staff to the South Central Region, Operational Excellence, Revenue Cycle Services, Managed Care, and Business Analytics.

She earned her Masters in Health Administration from Indiana University Indianapolis and received her Bachelor of Science in Health Administration from Indiana University Bloomington and a Certificate in Business from the Kelley School of Business. Lesley is a Fellow in the American College of Healthcare Executives and is a Certified Lean Six Sigma Black Belt.

As a loyal Indiana University alumna, Lesley has been actively involved with the university in a variety of volunteer leadership roles since graduating. She joined the Master of Science Healthcare Management faculty at IU Bloomington in the Fall of 2022 where she now teaches Practicum I, Practicum II, and the Capstone program.

Lesley currently serves on the Board of Directors for Big Brothers Big Sisters of South Central Indiana, Indiana University Alumni Association Executive Council, and the development and marketing committees for Indiana University Health Momentum Indy. In her free time, she enjoys attending Indiana University sporting events, hiking, spending time with her two doodles, and is an avid cyclist.

Taryn Stone is a partner and chair of the Firm's Health Care Group, concentrating her practice on various aspects of health law. Taryn represents various providers and suppliers of health care services including hospitals, physicians, and medical device manufacturers on transactional and regulatory issues. Her practice includes counseling clients on matters involving Medicare conditions of participation, Medicare and Medicaid billing and reimbursement issues, the Stark and Anti-Kickback laws and similar state laws, the False Claims Act, HIPAA and other state privacy and security laws, and state licensure laws and regulations. She is also a member of the Firm's Internet of Things (IoT) Group.

Taryn has represented many health care providers on a wide variety of matters including structuring complex health care arrangements under the Stark and Anti-Kickback laws, the formation, operation and sale of physician group practices, negotiating contracts, mergers and acquisitions, employment matters and other business arrangements between providers, manufacturers and other entities. Previously, Taryn served as in-house counsel for a large, publicly traded home health and hospice company. Taryn also worked as a health care consultant for a national consulting firm helping clients develop and implement co-management arrangements.

Taryn graduated from Washington University in St. Louis in 2002 with a Bachelor of Arts. While at Wash U, she was captain of the Washington University Women's Swimming & Diving team. She received her juris doctorate, magna cum laude, from Indiana University School of Law-Indianapolis in 2005. While in law school, she was an articles editor for the Indiana Law Review, a volunteer in the school's pro bono Memberships American Health Lawyers Association Community Involvement Stanley K. Lacy Executive Leadership Series, Class XLII Women's Fund of Central Indiana, OPTIONS Class 16 Pro Bono Volunteer, Neighborhood Christian Legal Clinic Board Secretary and Member of the Executive and Finance Committees, Choices, Inc. Board Member, Intercollegiate YMCA Advisory Board Member, First Book of Greater Indianapolis Law Student Mentor, Leadership Council on Legal Diversity Past Chair, Indianapolis Alumni and Parents Admission Program for Washington University in St. Louis Co-Team Leader, Women's Build for Habitat for Humanity 2018 WISH (Women Inspiring Strength and Hope) Class for Make-A-Wish Ohio, Kentucky and Indiana program, a member of the Health Law Society, and a member of the Dean's Tutorial Society. Taryn is admitted to practice law in the states of Indiana and North Carolina.

Tracey Ward is the Chief Operating Officer, Innovation & Regulatory at Elanco Animal Health.  She leads a team focused on Operational Excellence, ensuring that cross functional processes and systems enable teams to operate efficiently and effectively to deliver innovation to customers.

With over 20 years in the industry, including a 2 year assignment in Basel, Switzerland, Tracey has held key leadership roles in Global Product Development, CMC (Chemistry, Manufacturing & Controls), Six Sigma, Regulatory and Pharmacovigilance.  She has contributed to many of Elanco’s key brands. A Lilly TEDx speaker & “Feather in Her Cap” nominee, she has a passion for leading change and coaching and developing others.

Tracey received her B.S. from Piedmont College and her M.S. in Analytical Chemistry from the University of Georgia.  She participated in the Harvard Agribusiness Review in 2017.

In her spare time, she enjoys cooking with her family, especially baking, which leads to a necessary passion for working out!  She loves to feed people, because where she comes from, that is how you show you care.  This passion is part of why she works for Elanco, where the vision is “Food and Companionship Enriching Life.”  She wants to provide products that help feed a growing population in need of safe, affordable, abundant food, as she believes that technology can help ensure no one goes to bed hungry.